Table III.
The relationship between expression of RACK1 in GC tissues and clinical pathological parameters.
| RACK1 expression | ||||
|---|---|---|---|---|
| Clinical features | n | Low | High | P-value |
| Sex | ||||
| Male | 43 | 31 | 12 | 0.156 |
| Female | 27 | 15 | 12 | |
| Age | ||||
| ≥60 | 26 | 15 | 11 | 0.227 |
| <60 | 44 | 31 | 13 | |
| Tumor Size | ||||
| ≤5 | 28 | 18 | 10 | 0.837 |
| >5 | 42 | 28 | 14 | |
| Differentiation level | ||||
| High-Middle | 30 | 12 | 18 | <0.001 |
| Low | 40 | 34 | 6 | |
| Infiltrate depth | ||||
| Submucosa | 3 | 2 | 1 | 0.923 |
| Muscular layer | 9 | 5 | 4 | |
| Fibrous membrane | 47 | 32 | 15 | |
| Outside | 11 | 7 | 4 | |
| Lymph node metastasis | ||||
| ≤6 | 44 | 28 | 16 | 0.028 |
| 7–14 | 18 | 12 | 6 | |
| ≥15 | 8 | 5 | 3 | |
| TNM stage | ||||
| StageI–II | 41 | 20 | 21 | <0.001 |
| Stage III–IV | 29 | 26 | 3 | |
T, tumor size; N, lymph node; M, metastasis.